Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$315,552,823
+$104,293,875 QoQ
Shares Held
2,455,664
+39.8% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#95
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $4,791,103,609 across 11 Drug Manufacturers - General names. MRK ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,277,161 | $1,531,865,340 | |
| 2 | JNJ |
Johnson & Johnson
|
3,563,268 | $904,963,170 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
12,226,954 | $704,517,086 | |
| 4 | ABBV |
AbbVie Inc.
|
2,280,159 | $573,779,209 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
2,455,664 | $315,552,823 | |
| 6 | PFE |
Pfizer Inc
|
12,896,296 | $310,542,805 | |
| 7 | AMGN |
Amgen Inc
|
613,694 | $222,230,868 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,705,761 | $215,505,842 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $315,552,823 | 2,455,664 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $211,258,948 | 1,756,247 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $177,518,989 | 1,686,481 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $132,110,098 | 1,574,051 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $117,807,334 | 1,488,218 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $148,134,605 | 1,650,341 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $510,686,545 | 5,133,560 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $749,834,859 | 6,602,984 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,124,973,320 | 9,087,022 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,165,797,643 | 8,835,147 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $822,535,181 | 7,544,810 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $735,079,673 | 7,140,162 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $855,526,842 | 7,414,220 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $785,699,935 | 7,385,092 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $822,845,914 | 7,416,367 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $602,108,147 | 6,991,502 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $523,952,802 | 5,746,987 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $376,680,716 | 4,590,868 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $360,994,324 | 4,710,260 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $353,190,501 | 4,702,310 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $440,797,247 | 5,667,960 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $336,964,654 | 4,371,053 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $409,012,410 | 5,000,154 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $455,175,889 | 5,487,350 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $425,627,982 | 5,504,045 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $475,530,239 | 6,180,536 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||